地氯雷他定联合卡介菌多糖核酸与自血疗法对慢性荨麻疹疗效观察
2015-01-09彭中荣黄敏廖世宏张建武王顺初
彭中荣+黄敏+廖世宏+张建武+王顺初

doi:10.3969/j.issn.1007-614x.2014.1.19
摘 要 目的:观察地氯雷他定联合卡介菌多糖核酸与自血疗法对慢性荨麻疹的临床疗效和安全性。方法:收治慢性荨麻疹患者112例,随机分为对照组和治疗组,对照组50例口服地氯雷他定,治疗组62例口服地氯雷他定联合卡介菌多糖核酸与自血疗法,12天1个疗程,共4个疗程,48天。经连续48天治疗后,比较两组临床疗效及不良反应情况。治疗4月后随访,统计两组的复发率。结果:治疗48天后,治疗组痊愈41例,总有效率95.1%;对照组痊愈22例,总有效率76%,两组疗效差异有统计学意义(P<0.05)。4个月后电话随访,治疗组复发2例,复发率3.25%,对照组8例,复发率16%,两组比较差异有统计学意义(P<0.05)。结论:地氯雷他定联合卡介菌多糖核酸与自血疗法对慢性荨麻疹疗效明显和安全有效。
关键词 慢性荨麻疹 地氯雷他定 卡介菌多糖核酸 自血疗法
Abstract Objective:To observe the clinical efficacy and safety of desloratadine combined with BCG polysaccharide nucleic acid and autohemotherapy on chronic urticaria.Methods:112 cases of chronic urticaria patients,there were randomly divided into control group and treatment group,50 cases of the control group oral desloratadine,62 cases of the treatment group oral desloratadine combined with BCG polysaccharide nucleic acid and autohemotherapy,12 days was 1 course of treatment,a total of 4 courses,a total of 48 days.After 48 days of treatment,compared the clinical efficacy and adverse reactions of two groups.The follow-up treatment after 4 months,statistics the relapse rate of two groups.Results:After 48 days treatment,41 cases of the treatment group were cured,the total effective rate was 95.1%.22 cases of the control group were cured,the total effective rate was 76%,the difference between the two groups were significant(P<0.05).Telephone follow-up after 4 months,the treatment group recur 2 cases,the recurrence rate was 3.25%,the control group recur 8 cases,the recurrence rate was 16%,the two groups had statistical significance(P<0.05).Conclusion:The tcurative effect of desloratadine combined with BCG polysaccharide nucleic acid and autohemotherapy on chronic urticaria was safe and effective,is worthy of clinical application.
Key words Chronic urticaria;Desloratadine;BCG polysaccharide nucleic acid;Autohemotherapy
慢性荨麻疹(CU)是指各种因素致使皮肤、黏膜、血管发生暂时性炎性充血与组织内水肿,是一种较常见且容易复发的过敏性皮肤病,病程>6周称为慢性。目前临床治疗慢性荨麻疹方法很多,但停药后多易发作,效果欠佳,严重影响患者的心理和生活质量。
2010年1月-2012年11月应用地氯雷他定联合卡介菌多糖核酸与自血疗法治疗慢性荨麻疹,其疗效显著,现报告如下。
资料与方法
所有病例均符合中华医学会皮肤性病学分会制定的《荨麻疹诊疗指南(2007版)》的诊断标准[1],病程超过6周,治疗前1个月未使用皮质类固醇激素及免疫抑制剂,1周内未服用使用对本组疾病有预防和治疗药物,无严重心、脑、肝、肾等器官疾病,排除其他类型如人工荨麻疹、胆碱能性荨麻疹等荨麻疹患者。……